Ownership

Braden Michael Leonard

Insider Reports History

Entity: Individual
Location: 156 S. First Street, Zionsville, IN
Signature: Braden Michael Leonard
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Braden Michael Leonard:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Gemini Therapeutics, Inc. /DE	10%+ Owner	Common Stock	5M	$338M	$67.65	Oct 26, 2022	Holding of BML Investment Partners, L.P.
ASTROTECH Corp	10%+ Owner	Common Stock	6.61M	$55.1M	$8.34	Dec 2, 2022	Holding of BML Investment Partners, L.P.(1)
ASTROTECH Corp	10%+ Owner	Common Stock	6.35M	$52.9M	$8.34	Nov 18, 2022	Holding of BML Investment Partners, L.P.
IMARA Inc.	10%+ Owner	Common Stock	1.77M	$26.8M	$15.14	Jan 4, 2023	Holding of BML Investment Partners, L.P.
Aclaris Therapeutics, Inc.	10%+ Owner	Common Stock	14.3M	$17.7M	$1.24	Aug 5, 2024	Holding of BML Investment Partners, L.P
Gemini Therapeutics, Inc. /DE	10%+ Owner	Common Stock	248K	$16.7M	$67.65	Oct 26, 2022	Direct
Adverum Biotechnologies, Inc.	10%+ Owner	Common Stock	2.6M	$12M	$4.60	Feb 28, 2025	Holding of BML Investment Partners, L.P.
Cyteir Therapeutics, Inc.	10%+ Owner	Common Stock, par value $0.001 per share	3.65M	$10.8M	$2.95	Mar 20, 2024	Holding of BML Investment Partners, L.P
AN2 Therapeutics, Inc.	10%+ Owner	Common Stock	5.75M	$5.98M	$1.04	Aug 14, 2024	Holding of BML Investment Partners, L.P.
Satsuma Pharmaceuticals, Inc.	10%+ Owner	Common Stock	6.44M	$5.86M	$0.91	Nov 21, 2022	Holding of BML Investment Partners, L.P.
IMARA Inc.	10%+ Owner	Common Stock	230K	$3.48M	$15.14	Jan 3, 2023	Direct
ASTROTECH Corp	10%+ Owner	Common Stock	350K	$2.92M	$8.34	Dec 2, 2022	Direct
Metacrine, Inc.	10%+ Owner	Common Stock	6.16M	$2.9M	$0.47	Dec 21, 2022	Holding of BML Investment Partners, L.P.
Cyteir Therapeutics, Inc.	10%+ Owner	Common Stock, par value $0.001 per share	335K	$988K	$2.95	Mar 20, 2024	Direct
RETRACTABLE TECHNOLOGIES INC	10%+ Owner	Common Stock	689K	$847K	$1.23	Dec 29, 2022	Holding of BML Investment Partners, L.P.
Tectonic Therapeutic, Inc.	Former 10% owner of AVROBIO	Common Stock	400K	$520K	$1.30	Jun 20, 2024	Holding of BML Investment Partners, L.P,
Reneo Pharmaceuticals, Inc.	Former 10% owner of RPHM	Common Stock	346K	$517K	$1.50	Oct 7, 2024	Holdings of BML Investment Partners, L.P.
Adverum Biotechnologies, Inc.	10%+ Owner	Common Stock	105K	$482K	$4.60	Feb 26, 2025	Direct
RETRACTABLE TECHNOLOGIES INC	10%+ Owner	Common Stock	388K	$477K	$1.23	Dec 29, 2022	Direct
Talis Biomedical Corp	10%+ Owner	Common Stock	249K	$369K	$1.48	Sep 6, 2024	Holding of BML Investment Partners, L.P.
Metacrine, Inc.	10%+ Owner	Common Stock	600K	$282K	$0.47	Dec 19, 2022	Direct
Reneo Pharmaceuticals, Inc.	Former 10% owner of RPHM	Common Stock	102K	$153K	$1.50	Oct 7, 2024	Direct
Satsuma Pharmaceuticals, Inc.	10%+ Owner	Common Stock	150K	$137K	$0.91	Nov 21, 2022	Direct
Tectonic Therapeutic, Inc.	Former 10% owner of AVROBIO	Common Stock	33.3K	$43.3K	$1.30	Jun 20, 2024	Direct
RETRACTABLE TECHNOLOGIES INC	10%+ Owner	Put Option (obligation to buy)	0			Nov 28, 2022	Holding of BML Investment Partners, L.P.

Previous1Next

Showing 1 to 25 of 25 entries

Insider Reports Filed by Braden Michael Leonard

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
ADVM	Adverum Biotechnologies, Inc.	Feb 26, 2025	3	$1.44M	4	Feb 28, 2025	10%+ Owner
OKUR	OnKure Therapeutics, Inc.	Oct 7, 2024	2	$0	4	Oct 9, 2024	Former 10% owner of RPHM
RPHM	Reneo Pharmaceuticals, Inc.	Sep 24, 2024	2	$145K	4	Sep 26, 2024	10%+ Owner
RPHM	Reneo Pharmaceuticals, Inc.	Sep 17, 2024	2	$76.2K	4	Sep 19, 2024	10%+ Owner
RPHM	Reneo Pharmaceuticals, Inc.	Sep 12, 2024	3	$484K	4	Sep 16, 2024	10%+ Owner
TLIS	Talis Biomedical Corp	Sep 5, 2024	2	$44.2K	4	Sep 9, 2024	10%+ Owner
TLIS	Talis Biomedical Corp	Sep 3, 2024	1	$2K	4	Sep 5, 2024	10%+ Owner
TLIS	Talis Biomedical Corp	Aug 30, 2024	1	$642	4	Sep 4, 2024	10%+ Owner
TLIS	Talis Biomedical Corp	Aug 28, 2024	2	$56.1K	4	Aug 28, 2024	10%+ Owner
TLIS	Talis Biomedical Corp	Aug 14, 2024	0	$0	3	Aug 14, 2024	10%+ Owner
ANTX	AN2 Therapeutics, Inc.	Aug 14, 2024	1	$1.56M	4	Aug 14, 2024	10%+ Owner
RPHM	Reneo Pharmaceuticals, Inc.	Aug 13, 2024	2	$381K	4	Aug 14, 2024	10%+ Owner
ANTX	AN2 Therapeutics, Inc.	Aug 9, 2024	0	$0	3	Aug 12, 2024	10%+ Owner
ACRS	Aclaris Therapeutics, Inc.	Aug 2, 2024	2	$473K	4	Aug 5, 2024	10%+ Owner
ADVM	Adverum Biotechnologies, Inc.	Jul 30, 2024	1	$613K	4	Jul 31, 2024	10%+ Owner
ACRS	Aclaris Therapeutics, Inc.	Jul 30, 2024	2	$359K	4	Jul 31, 2024	10%+ Owner
ACRS	Aclaris Therapeutics, Inc.	Jul 18, 2024	3	$202K	4	Jul 22, 2024	10%+ Owner
ADVM	Adverum Biotechnologies, Inc.	Jul 18, 2024	2	$1.79M	4	Jul 18, 2024	10%+ Owner
ADVM	Adverum Biotechnologies, Inc.	Jul 17, 2024	0	$0	3	Jul 18, 2024	10%+ Owner
ACRS	Aclaris Therapeutics, Inc.	Jul 2, 2024	3	$406K	4	Jul 5, 2024	10%+ Owner
ACRS	Aclaris Therapeutics, Inc.	Jun 27, 2024	4	$1.74M	4	Jul 1, 2024	10%+ Owner
TECX	Tectonic Therapeutic, Inc.	Jun 20, 2024	2	$0	4	Jun 25, 2024	Former 10% owner of AVROBIO
ACRS	Aclaris Therapeutics, Inc.	Jun 14, 2024	3	$628K	4	Jun 18, 2024	10%+ Owner
ACRS	Aclaris Therapeutics, Inc.	Jun 11, 2024	4	$1.78M	4	Jun 13, 2024	10%+ Owner
RPHM	Reneo Pharmaceuticals, Inc.	May 14, 2024	2	$640K	4	May 16, 2024	10%+ Owner
RPHM	Reneo Pharmaceuticals, Inc.	May 14, 2024	0	$0	3	May 16, 2024	10%+ Owner
AVRO	AVROBIO, Inc.	May 13, 2024	3	$971K	4	May 15, 2024	10%+ Owner
AVRO	AVROBIO, Inc.	May 13, 2024	0	$0	3/A	May 15, 2024	10%+ Owner
AVRO	AVROBIO, Inc.	May 13, 2024	0	$0	3	May 15, 2024	10%+ Owner
CYT	Cyteir Therapeutics, Inc.	Mar 20, 2024	1	$503K	4	Mar 25, 2024	10%+ Owner
CYT	Cyteir Therapeutics, Inc.	Mar 19, 2024	1	$342K	4	Mar 19, 2024	10%+ Owner
CYT	Cyteir Therapeutics, Inc.	Mar 15, 2024	0	$0	3	Mar 19, 2024	10%+ Owner
ACRS	Aclaris Therapeutics, Inc.	Feb 7, 2024	0	$0	3	Feb 8, 2024	10%+ Owner
ELVN	IMARA Inc.	Jan 3, 2023	1	-$5M	4/A	Jan 5, 2023	10%+ Owner
ELVN	IMARA Inc.	Dec 30, 2022	1	-$80.8K	4	Dec 30, 2022	10%+ Owner
RVP	RETRACTABLE TECHNOLOGIES INC	Dec 29, 2022	1	-$4.8M	4	Dec 29, 2022	10%+ Owner
ELVN	IMARA Inc.	Dec 28, 2022	2	-$80.8K	4	Dec 29, 2022	10%+ Owner
ELVN	IMARA Inc.	Dec 22, 2022	2	-$203K	4	Dec 27, 2022	10%+ Owner
MTCR	Metacrine, Inc.	Dec 19, 2022	3	$108K	4	Dec 21, 2022	10%+ Owner
ASTC	ASTROTECH Corp	Dec 2, 2022	1	$65.6K	4	Dec 2, 2022	10%+ Owner
RVP	RETRACTABLE TECHNOLOGIES INC	Nov 28, 2022	2	-$506K	4	Nov 30, 2022	10%+ Owner
ASTC	ASTROTECH Corp	Nov 23, 2022	1	$24.7K	4	Nov 25, 2022	10%+ Owner
STSA	Satsuma Pharmaceuticals, Inc.	Nov 21, 2022	1	$107K	4	Nov 23, 2022	10%+ Owner
ASTC	ASTROTECH Corp	Nov 16, 2022	3	$145K	4	Nov 18, 2022	10%+ Owner
STSA	Satsuma Pharmaceuticals, Inc.	Nov 14, 2022	3	$4.39M	4	Nov 16, 2022	10%+ Owner
STSA	Satsuma Pharmaceuticals, Inc.	Nov 14, 2022	0	$0	3	Nov 16, 2022	10%+ Owner
MTCR	Metacrine, Inc.	Nov 7, 2022	3	$68.1K	4	Nov 9, 2022	10%+ Owner
MTCR	Metacrine, Inc.	Oct 27, 2022	2	$317K	4	Oct 31, 2022	10%+ Owner
IRON	Gemini Therapeutics, Inc. /DE	Oct 26, 2022	1	-$47K	4	Oct 27, 2022	10%+ Owner
MTCR	Metacrine, Inc.	Oct 24, 2022	3	$443K	4	Oct 26, 2022	10%+ Owner
MTCR	Metacrine, Inc.	Oct 24, 2022	0	$0	3	Oct 26, 2022	10%+ Owner
ASTC	ASTROTECH Corp	Oct 14, 2022	2	$81.8K	4	Oct 18, 2022	10%+ Owner
ASTC	ASTROTECH Corp	Sep 23, 2022	3	$157K	4	Sep 27, 2022	10%+ Owner
ASTC	ASTROTECH Corp	Sep 1, 2022	2	$117K	4	Sep 7, 2022	10%+ Owner
ASTC	ASTROTECH Corp	Aug 24, 2022	0	$0	3	Aug 25, 2022	10%+ Owner
ASTC	ASTROTECH Corp	Aug 23, 2022	2	$219K	4	Aug 25, 2022	10%+ Owner
ELVN	IMARA Inc.	Jun 16, 2022	1	$92.2K	4	Jun 21, 2022	10%+ Owner
ELVN	IMARA Inc.	Jun 3, 2022	2	$38K	4	Jun 7, 2022	10%+ Owner
RVP	RETRACTABLE TECHNOLOGIES INC	May 23, 2022	2	$253K	4	May 25, 2022	10%+ Owner
RVP	RETRACTABLE TECHNOLOGIES INC	May 17, 2022	3	$535K	4	May 19, 2022	10%+ Owner
ELVN	IMARA Inc.	May 16, 2022	2	$50.4K	4	May 18, 2022	10%+ Owner
RVP	RETRACTABLE TECHNOLOGIES INC	May 12, 2022	3	$554K	4	May 16, 2022	10%+ Owner
RVP	RETRACTABLE TECHNOLOGIES INC	May 9, 2022	3	$281K	4	May 11, 2022	10%+ Owner
RVP	RETRACTABLE TECHNOLOGIES INC	Apr 28, 2022	3	$1.6M	4	May 2, 2022	10%+ Owner
RVP	RETRACTABLE TECHNOLOGIES INC	Apr 28, 2022	0	$0	3	May 2, 2022	10%+ Owner
ELVN	IMARA Inc.	Apr 21, 2022	2	$784K	4	Apr 25, 2022	10%+ Owner
ELVN	IMARA Inc.	Apr 21, 2022	0	$0	3	Apr 25, 2022	10%+ Owner
IRON	Gemini Therapeutics, Inc. /DE	Apr 11, 2022	4	$1.34M	4	Apr 13, 2022	10%+ Owner
IRON	Gemini Therapeutics, Inc. /DE	Apr 11, 2022	0	$0	3	Apr 13, 2022	10%+ Owner